stroke therapy (deCODE/Roche)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug Namestroke therapy (deCODE/Roche)
Drug Alias NamePDE4D inhibitors (deCODE/Roche)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActioncAMP-specific 3',5'-cyclic phosphodiesterase 4D inhibitors
TargetscAMP-specific 3',5'-cyclic phosphodiesterase 4D
Therapy Area/IndicationsStroke
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryIceland
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesDecode Genetics
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesF. Hoffmann-La Roche LtdDecode Genetics
Active IndicationsN/A
Inactive IndicationsStroke

Other Information

ATC CodeN/A
Related LinksN/A